GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuneOnco Biopharmaceuticals (Shanghai) Inc (FRA:R9Z) » Definitions » Total Operating Expense

ImmuneOnco Biopharmaceuticals (Shanghai) (FRA:R9Z) Total Operating Expense : €46.96 Mil (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is ImmuneOnco Biopharmaceuticals (Shanghai) Total Operating Expense?

ImmuneOnco Biopharmaceuticals (Shanghai)'s Total Operating Expense for the three months ended in Jun. 2024 was €0.00 Mil. ImmuneOnco Biopharmaceuticals (Shanghai)'s Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was €46.96 Mil.

ImmuneOnco Biopharmaceuticals (Shanghai) Total Operating Expense Historical Data

The historical data trend for ImmuneOnco Biopharmaceuticals (Shanghai)'s Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuneOnco Biopharmaceuticals (Shanghai) Total Operating Expense Chart

ImmuneOnco Biopharmaceuticals (Shanghai) Annual Data
Trend Dec21 Dec22 Dec23
Total Operating Expense
30.63 51.82 50.22

ImmuneOnco Biopharmaceuticals (Shanghai) Quarterly Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Operating Expense Get a 7-Day Free Trial 23.00 27.38 21.69 25.27 -

ImmuneOnco Biopharmaceuticals (Shanghai) Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €46.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImmuneOnco Biopharmaceuticals (Shanghai) Total Operating Expense Related Terms

Thank you for viewing the detailed overview of ImmuneOnco Biopharmaceuticals (Shanghai)'s Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmuneOnco Biopharmaceuticals (Shanghai) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuneOnco Biopharmaceuticals (Shanghai) Inc (FRA:R9Z) » Definitions » Total Operating Expense
Comparable Companies
Traded in Other Exchanges
01541:Hong Kong
Address
1000 Zhangheng Road, Unit 15, China (Shanghai) Pilot Free Trade Zone, Pudong New Area, Shanghai, CHN
Website
http://cn.immuneonco.com
ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.

ImmuneOnco Biopharmaceuticals (Shanghai) Headlines

No Headlines